{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:05Z","timestamp":1789684985060,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA168524"],"award-info":[{"award-number":["P30-CA168524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["125618-RSG-14-067-01-TBE"],"award-info":[{"award-number":["125618-RSG-14-067-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["131101-PF-17-241-01-CCG"],"award-info":[{"award-number":["131101-PF-17-241-01-CCG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-10-1-0386"],"award-info":[{"award-number":["W81XWH-10-1-0386"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00970","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T02:06:37Z","timestamp":1515636397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy"],"prefix":"10.3389","volume":"8","author":[{"given":"Derek B.","family":"Oien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1349-7006.1992.tb01959.x","article-title":"The number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with cisplatin at its mean lethal concentration","volume":"83","author":"Akaboshi","year":"1992","journal-title":"Jpn. J. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1021\/js960037a","article-title":"Pharmacokinetics of cisplatin and its monohydrated complex in humans","volume":"85","author":"Andersson","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1139\/Y06-101","article-title":"Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells","volume":"85","author":"Azar","year":"2007","journal-title":"Can. J. Physiol. Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10146","DOI":"10.18632\/oncotarget.3380","article-title":"Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer","volume":"6","author":"Bae","year":"2015","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0032-1306261","article-title":"Effects of oxidative stress on intestinal type I insulin-like growth factor receptor expression","volume":"22","author":"Baregamian","year":"2012","journal-title":"Eur. J. Pediatr. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.molonc.2016.09.005","article-title":"VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal","volume":"10","author":"Bastola","year":"2016","journal-title":"Mol. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16848","DOI":"10.18632\/oncotarget.4253","article-title":"Reactive oxygen species a double-edged sword for mesothelioma","volume":"6","author":"Benedetti","year":"2015","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ijc.22132","article-title":"Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA","volume":"120","author":"Berndtsson","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"Bonelli","year":"2016","journal-title":"Biochem. Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"B11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2008.02.029","article-title":"Mechanisms of ROS modulated cell survival during carcinogenesis","volume":"266","author":"Clerkin","year":"2008","journal-title":"Cancer Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e23240","DOI":"10.1371\/journal.pone.0023240","article-title":"EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization","volume":"6","author":"Filosto","year":"2011","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/ijc.29848","article-title":"Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification","volume":"138","author":"Furugaki","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1016\/j.yexcr.2013.08.018","article-title":"Cell migration or cytokinesis and proliferation?\u2013revisiting the \u201cgo or grow\u201d hypothesis in cancer cells in vitro","volume":"319","author":"Garay","year":"2013","journal-title":"Exp. Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","article-title":"E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis","volume":"89","author":"Godwin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1038\/ncomms7139","article-title":"Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition","volume":"6","author":"Goldman","year":"2015","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-15-0846","article-title":"Trabectedin is active against malignant pleural mesothelioma cell and xenograft models and synergizes with chemotherapy and Bcl-2 inhibition in vitro","volume":"15","author":"Hoda","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","article-title":"R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer","volume":"70","author":"Holland","year":"2010","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.canlet.2008.04.017","article-title":"Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia","volume":"268","author":"Hong","year":"2008","journal-title":"Cancer Lett"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/bioinformatics\/btm283","article-title":"Non-parametric quantification of protein lysate arrays","volume":"23","author":"Hu","year":"2007","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.freeradbiomed.2013.09.011","article-title":"Oxidative stress enhances Axl-mediated cell migration through an Akt1\/Rac1-dependent mechanism","volume":"65","author":"Huang","year":"2013","journal-title":"Free Radic. Biol. Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3892\/or.2015.3830","article-title":"Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1","volume":"33","author":"Hwang","year":"2015","journal-title":"Oncol. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000149782","article-title":"Acquisition of cisplatin-resistance in malignant mesothelioma cells abrogates Na+,K+,2Cl\u2212-cotransport activity and cisplatin-induced early membrane blebbing","volume":"22","author":"Janson","year":"2008","journal-title":"Cell. Physiol. Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"28766","DOI":"10.1074\/jbc.M401977200","article-title":"Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells","volume":"279","author":"Konishi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B26","first-page":"2858","article-title":"Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules","volume":"53","author":"Lee","year":"1993","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"B28","first-page":"1955","article-title":"Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues","volume":"42","author":"Marklund","year":"1982","journal-title":"Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/01.RES.83.7.697","article-title":"Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats","volume":"83","author":"Melaragno","year":"1998","journal-title":"Circul. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/acs.jmedchem.5b01273","article-title":"AXL inhibitors in cancer: a medicinal chemistry perspective","volume":"59","author":"Myers","year":"2016","journal-title":"J. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.2004652","article-title":"Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer","volume":"6","author":"Niederst","year":"2013","journal-title":"Sci. Signal."},{"key":"B32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br. J. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S514","DOI":"10.21037\/tcr.2016.09.32","article-title":"Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent gluathione pathway","volume":"5","author":"Oien","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0070-2153(07)80003-2","article-title":"Substrates of the methionine sulfoxide reductase system and their physiological relevance","volume":"80","author":"Oien","year":"2008","journal-title":"Curr. Top. Dev. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1471-4159.2010.06721.x","article-title":"Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse","volume":"114","author":"Oien","year":"2010","journal-title":"J. Neurochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12031-009-9274-8","article-title":"Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells","volume":"39","author":"Oien","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/onc.2010.555","article-title":"AXL regulates mesothelioma proliferation and invasiveness","volume":"30","author":"Ou","year":"2011","journal-title":"Oncogene"},{"key":"B38","first-page":"333","article-title":"Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers","volume":"152","author":"Pache","year":"1998","journal-title":"Am. J. Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00221-007-0903-6","article-title":"Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse","volume":"180","author":"Pal","year":"2007","journal-title":"Exp. Brain Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/1078-0432.CCR-0607-3","article-title":"Gene expression profiles predict survival and progression of pleural mesothelioma","volume":"10","author":"Pass","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/carcin\/11.4.673","article-title":"Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients","volume":"11","author":"Pelin-Enlund","year":"1990","journal-title":"Carcinogenesis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/ijms17030322","article-title":"Asbestos induces oxidative stress and activation of Nrf2 signaling in murine macrophages: chemopreventive role of the synthetic lignan secoisolariciresinol diglucoside (LGM2605)","volume":"17","author":"Pietrofesa","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1158\/0008-5472.CAN-05-1162","article-title":"Resistance to paclitaxel is proportional to cellular total antioxidant capacity","volume":"65","author":"Ramanathan","year":"2005","journal-title":"Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"31214","DOI":"10.1074\/jbc.M204677200","article-title":"Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation","volume":"277","author":"Ravid","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1097\/01.ASN.0000077404.45564.7E","article-title":"W. Cellular regulation by hydrogen peroxide","volume":"14","author":"Rhee","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1164\/rccm.201404-0658OC","article-title":"Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy","volume":"190","author":"Schelch","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Schmitter","year":"1992","journal-title":"Int. J. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.vph.2010.07.002","article-title":"Pharmacological inhibition of Axl affects smooth muscle cell functions under oxidative stress","volume":"53","author":"Smolock","year":"2010","journal-title":"Vasc. Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2741\/1667","article-title":"Reactive oxygen species in tumor progression","volume":"10","author":"Storz","year":"2005","journal-title":"Front. Biosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J. Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/1078-0432.CCR-05-1834","article-title":"Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer","volume":"12","author":"Sweeney","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"B52","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/bi301441e","article-title":"Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation","volume":"51","author":"Truong","year":"2012","journal-title":"Biochemistry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbrc.2005.05.086","article-title":"Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation","volume":"333","author":"Valverde","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.7150\/thno.15083","article-title":"Gas6\/Axl axis contributes to chemoresistance and metastasis in breast cancer through Akt\/GSK-3beta\/beta-catenin signaling","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"120144","DOI":"10.1098\/rsob.120144","article-title":"Oxidants, antioxidants and the current incurability of metastatic cancers","volume":"3","author":"Watson","year":"2013","journal-title":"Open Biol."},{"key":"B57","article-title":"Bgb324, a selective small molecule axl kinase inhibitor to overcome emt-associated drug resistance in carcinomas: therapeutic rationale and early clinical studies","volume-title":"Proceedings of the 105th Annual Meeting of the American Association for Cancer Research:nr 1747","author":"Wnuk-Lipinska","year":"2014"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.18632\/oncotarget.2542","article-title":"AXL kinase as a novel target for cancer therapy","volume":"5","author":"Wu","year":"2014","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ng.2330","article-title":"Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat. Genet."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T11:21:54Z","timestamp":1526383314000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":60,"alternative-id":["10.3389\/fphar.2017.00970"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00970","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]},"article-number":"970"}}